Daily Bulletin

The Times Real Estate

.

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

Why Professional Window Cleaning Is a Must for Melbourne Homes

Let us be honest when was the last time you cleaned your windows properly? Not just a quick wipe, but a proper clean that got into all the corners, sills, and second-storey panes. If you are like mo...

Daily Bulletin - avatar Daily Bulletin

pay.com.au unlocks untapped value through Avios and British Airways partnership

British Airways joins a growing list of transfer partners including Cathay Pacific and Thai Airways, empowering SMEs with expanded redemption options and flexibility  AUSTRALIA, 29 April 2025 — p...

Daily Bulletin - avatar Daily Bulletin

Why Ignoring a Windshield Chip Could Cost You More in the Long Run

(Source) When a stone from the road jumps to your windshield, you hear the distinctive tap. You check the glass window through your reflection to discover one tiny chip that seems insignificant. A sm...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals